Navigation Links
Key to Long Life

Families who live long and healthy lives probably have significantly larger high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, //according to a new study. Lipoproteins are the particles that carry fat through the blood.

Previous studies suggest genetic determinants of exceptional longevity are highly heritable. This study’s goal was to identify the specific biological or genetic factors that determine long life in individuals. They recruited more than 200 people over age 98 and their children. They found these families have significantly larger HDL and LDL particle sizes. The sizes of the particles were not dependent on the levels of lipoproteins in the blood.

In addition to living longer, these people have generally been spared from age-related diseases such as cardiovascular disease, diabetes, Alzheimer’s disease and cancer. The authors say their study cannot directly conclude larger particle sizes play a direct biological role in successful aging, but they do suggest that lipoprotein concentrations and particle sizes are excellent causal biological candidates. For example, HDL and LDL particle sizes are significantly larger in women than in men and may explain, in part, why women have lower cardiovascular disease incidence rates and higher life expectancies than men.

In looking at the offspring of long-living individuals, the researchers found LDL and HDL particle sizes are significant predictors of having longevity, even after taking into account absolute level of lipids, lipoproteins and body mass index. They also say LDL particle size may be a stronger predictor of cardiovascular disease than LDL levels.

The researchers conclude that although further research is needed, these findings may provide key insights into preventative and therapeutic interventions of several age-related diseases that cause significant mortality in the elderl.
'"/>




Page: 1

Related medicine news :

1. Life after Bypass not so Promising for Women.
2. Promising cure for West Nile Virus
3. Deadly Diarrhoea Vaccine – Trail Results Promising
4. Novartis MS Drug Shows Promising Results
5. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
6. Promising Care Model For Bipolar Disorder
7. A Promising New Vaccination Strategy for Late-Stage Melanoma
8. Promising Brain Tumor Treatment In The Offing
9. Sea Creatures Toxin Could Lead to Promising Cancer Treatment
10. Vaccine Promising Against Hepatitis E
11. Groups Join Forces to Fund Promising Lung Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: